Ajust text size (less) Ajust text size (more)
Adjust text size
 

National webinars and special events

Back to previous page

PSA is excited to offer a national webinar series available to all members across Australia.

The one hour monthly webinar will enable you to interactively engage and question the expert speakers in real time from anywhere in Australia.

Multiple choice questions will be available online to enable you to gain Group 2 Credits for each webinar.

Webinars will be recorded and accessible to view a few days after the live webinar via the PSA Online Learning listing.

Feb
28
Wed
2018
An introduction to the Endocannabinoid System – Webinar @ Online
Feb 28 @ 7:30 pm – 8:00 pm
MCC_logo PSA proudly hosts this education on behalf of Medical Cannabis Council as part of our commitment to meet pharmacist’s educational needs.

Overview

The endocannabinoid system is a major neuromodulatory system involved in regulating a variety of physiological and cognitive processes including mediating the pharmacological effects of cannabis. This webinar will provide viewers with an overview of how medicinal cannabis interacts with the human body through an explanation of the endocannabinoid system.

Time

ACT, NSW, TAS & VIC – 7.30pm
QLD – 6.30pm
SA – 7:00pm
NT – 6:00pm
WA – 4.30pm

register now button

*Please use your PSA number at registration to have your CPD credits automatically recorded to your PSA member record.

Learning Objectives:

After completing this activity, pharmacists should be able to:

  • Describe the different cannabinoid receptors, endocannabinoids (ligands) and enzymes that constitute the endocannabinoid system
  • Define the physiological activity of the endocannabinoid system, with specific examples focusing on the neurological, cardiovascular, gastrointestinal and immune systems
  • Describe potential interactions via cytochrome P450 liver enzymes, and describe the benefits and disadvantages of different forms of administration.

Competencies (2016) addressed: 3.1.2, 3.5.2, 3.6.3.

Competencies (2010) addressed: 4.2.1, 7.3.1, 6.3.1.

CPD Points:

PSA-Credit-icons_group-2-1

PSA is currently seeking accreditation of this activity. This activity may attract up to 1 hour of Group 2 CPD (or 2 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan.

Speaker

Justin Sinclair MHerbMed (USyd) BHSc (UNR) FNHAA MICRS MSCC
Justin is a research Fellow at NICM, international leader in integrative medicine research based at Western Sydney University; coordinator of the Australian Medicinal Cannabis Research & Education Collaboration. For the last 2 years he has served on the United in Compassion’s Scientific Advisory Board, Australia’s leading medicinal cannabis patient advocacy group (pro bono). His scientific background is in pharmacognosy, but research interests extend into botany, ethnopharmacology, analytical phytochemistry, ethnobotany and psychopharmacology. He is currently a co-investigator on several clinical research projects in development around medicinal cannabis, and lectures to medical practitioners, nurses, politicians and other allied health professionals about therapeutic applications of the Cannabis genus. He has published on the topics of cannabis and the endocannabinoid system, pain management and herb/drug interactions in peer reviewed publications and is a member of the Society of Cannabis Clinicians and International Cannabinoid Research Society.

This item is listed in the following categories: • Branch events


Back

our vision: Improving Australia's health through excellence in pharmacist care

' • '